Dublin, July 24, 2017 -- The "Global Sleep Apnea Market - Trends and Forecast to 2024" report has been added to Research and Markets' offering.
Global Sleep Apnea Devices Market is Expected to Reach USD 7.1 Billion by 2024, at a CAGR 7.8% During the Forecast Period of 2017 to 2024
Globally, there is an exponential rise in the cases of Obstructive Sleep Apnea (OSA) among the world population and is one of the most important factors contributing to the growth of this market. It is estimated that around 100 million people suffer from OSA across the world. Factors which cause development of sleep apnea include obesity, life style habits such as smoking, alcohol, irregular sleep patterns, and substance abuse. The risk of sleep apnea is higher in the age group above 50-60 years.
It is found that more than 18 million adults across different age groups have sleep apnea and approx two to three percent cases are related to childhood OSA. The numbers are much higher in children with habitual snoring. The most common conditions associated with this disorder include atrial fibrillation, coronary artery disease, respiratory diseases, stroke, congestive heart failure, obesity, and hypertension and type II diabetes.
Key Topics Covered:
1 Introduction
1.1. Overview of the Sleep Apnea Devices Market
1.2. Market Segmentation & Coverage
1.2.1. Currency and Pricing
1.2.2. Limitation
2 Research Methodology
3 Market Landscape Summary
4 Premium Insights
4.1. Overview
4.2. Sleep Apnea Devices Market: Key Primary Insights
4.3. Market Overview
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Threats
4.4. Key Market Trends and Upcoming Technologies
5 Sleep Apnea Devices Market, by Type
5.1. Overview
5.2. Sleep Apnea Therapeutic Devices
5.2. Sleep Apnea Diagnostic Devices
6 Sleep Apnea Therapeutic Devices Market, by Product Type
6.1. Overview
6.2. Positive Airway Pressure Devices Market (PAP)
6.2.1. Continuous Airway Pressure Devices Market (CPAP)
6.2.2. Bi-Level Airway Pressure Devices Market (BiPAP)
6.2.3. Variable Positive Airway Pressure (VPAP)
6.2.4. Automatically-Adjusting Positive Airway Pressure (APAP)
6.3. Masks
6.3.1. Non-Vented Masks
6.3.2. Nasal Masks
6.3.3. Nasal Pillows
6.3.4. Full Face Masks
6.3.5. Paediatric Masks
6.3.6. Others
6.4. Adaptive Servo-Ventilation (ASV)
6.5. Airway Clearance Systems
6.6. Oxygen Concentrators
6.6.1. Stationary Concentrators
6.6.2. Portable Concentrators
6.7. Oral Sleep Apnea Devices
6.7.1. Mandibular Advancement Devices (MAD)
6.7.2. Tongue Retaining Device (TRD)
6.8. Accessories
7 Sleep Apnea Diagnostic Devices Market, by Product Type
7.1. Overview
7.2. Pulse Oximeters
7.2.1. Handheld Pulse Oximeters
7.2.2. Fingertip Pulse Oximeters
7.2.3. Tabletop Pulse Oximeters
7.2.4. Wrist-Worn Pulse Oximeters
7.3. Polysomnograph (PSG)
7.3.1. Clinical PSG
7.3.2. Ambulatory PSG Devices
7.4. Respiratory Polygraph
7.5. Actigraph
8 Sleep Apnea Devices Market, by End User
8.1. Overview
8.2. Diagnostic Devices
8.2.1. Hospitals
8.2.2. Home Healthcare
8.2.3. Sleep Clinics
8.2.4. Community Healthcare
8.3. Therapeutic Devices
8.3.1. Hospitals
8.3.2. Home Healthcare
8.3.3. Sleep Clinics
8.3.4. Community Healthcare
9 Sleep Apnea Devices Market, by Apnea Type
9.1. Sleep Apnea Diagnostic Devices Market, by Apnea Type
9.1.1. Obstructive Sleep Apnea
9.1.2. Central Sleep Apnea
9.1.3. Complex Sleep Apnea
9.2. Sleep Apnea Therapeutic Devices Market, by Apnea Type
9.2.1. Obstructive Sleep Apnea
9.2.2. Central Sleep Apnea
9.3.3. Complex Sleep Apnea
9.3. Sleep Apnea Patient Volume, by Apnea Type
9.3.1. Obstructive Sleep Apnea
9.3.2. Central Sleep Apnea
9.3.3. Complex Sleep Apnea
10 Sleep Apnea Devices Market, by Geography
11 Sleep Apnea Devices Market: Competitive Landscape
12 Sleep Apnea Devices Market, Company Profiles
- Ambulatory Monitoring Inc.
- BMC Medical Co. Ltd.
- Carefusion Corporation
- Cleveland Medical Devices Inc.
- Compumedics Limited
- Contec Medical Systems Co. Ltd.
- Curative Medical Inc.
- Custo Med GmbH
- Devilbiss Healthcare
- Ergoline GmbH
- Fisher and Paykel Healthcare Ltd.
- Global Medical Holdings LLC
- Heinen Lowenstein GmbH & Co. KG
- Itamar Medical Ltd.
- Medicom Mtd Ltd.
- Natus Medical Inc.
- Neurovirtual
- Philips Respironics
- Resmed
- Sibelgroup
- Somnetics International Inc.
- Somnomed
- Somnomedics GmbH
- Weinmann Medical Devices Gmbh & Co. Kg
For more information about this report visit https://www.researchandmarkets.com/research/rb9df6/global_sleep
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Britain Courts Anthropic Amid US Defense Department Dispute
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 



